請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/54854
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 劉貞佑(Chen-Yu Liu) | |
dc.contributor.author | Pei-Chen Lien | en |
dc.contributor.author | 連培真 | zh_TW |
dc.date.accessioned | 2021-06-16T03:39:57Z | - |
dc.date.available | 2020-03-12 | |
dc.date.copyright | 2015-03-12 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2015-02-16 | |
dc.identifier.citation | 1. Stahl, T., Mattern, D. Brunn, H. Toxicology of perfluorinated compounds. Environmental Sciences Europe 23, 1-52 (2011). 2. European Union. DIRECTIVE 2006/122/ECOF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 12 December 2006. Official Journal of the European Union L 372, 32-34 (2006). 3. U.S. Environmental Protection Agency. 2010/2015 PFOA Stewardship Program. Vol. 2014. 4. Government of Canada. Perfluorooctane sulfonate and its salts and certain other compounds regulations. Canada Gazette Part I 140, 4265-4284 (2006). 5. 行政院環境保護署. 持久性有機污染物 - 公約第二批(COP4)新增9種POPs. Vol. 2014 (2014). 6. Fromme, H. et al. Occurrence of perfluorinated substances in an adult German population in southern Bavaria. Int Arch Occup Environ Health 80, 313-9 (2007). 7. Olsen, G.W. et al. Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115, 1298-305 (2007). 8. Hinderliter, P.M., Mylchreest, E., Gannon, S.A., Butenhoff, J.L. Kennedy, G.L., Jr. Perfluorooctanoate: Placental and lactational transport pharmacokinetics in rats. Toxicology 211, 139-48 (2005). 9. Tittlemier, S.A., Pepper, K. Edwards, L. Concentrations of perfluorooctanesulfonamides in Canadian total diet study composite food samples collected between 1992 and 2004. J Agric Food Chem 54, 8385-9 (2006). 10. Midasch, O., Drexler, H., Hart, N., Beckmann, M.W. Angerer, J. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int Arch Occup Environ Health 80, 643-8 (2007). 11. Inoue, K. et al. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 112, 1204-7 (2004). 12. Apelberg, B.J. et al. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 115, 1670-6 (2007). 13. Monroy, R. et al. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res 108, 56-62 (2008). 14. Lien, G.W. et al. Analysis of perfluorinated chemicals in umbilical cord blood by ultra-high performance liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 879, 641-6 (2011). 15. Apelberg, B.J. et al. Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland. Environ Sci Technol 41, 3891-7 (2007). 16. Washino, N. et al. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ Health Perspect 117, 660-7 (2009). 17. Chen, M.H. et al. Perfluorinated compounds in umbilical cord blood and adverse birth outcomes. PLoS One 7, e42474 (2012). 18. Andersen, C.S. et al. Prenatal exposures to perfluorinated chemicals and anthropometric measures in infancy. Am J Epidemiol 172, 1230-7 (2010). 19. Fei, C., McLaughlin, J.K., Tarone, R.E. Olsen, J. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 115, 1677-82 (2007). 20. Stein, C.R., Savitz, D.A. Dougan, M. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. Am J Epidemiol 170, 837-46 (2009). 21. Olsen, G.W., Burlew, M.M., Marshall, J.C., Burris, J.M. Mandel, J.H. Analysis of episodes of care in a perfluorooctanesulfonyl fluoride production facility. J Occup Environ Med 46, 837-46 (2004). 22. Nolan, L.A., Nolan, J.M., Shofer, F.S., Rodway, N.V. Emmett, E.A. The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod Toxicol 27, 231-8 (2009). 23. Barker, D.J. Adult consequences of fetal growth restriction. Clin Obstet Gynecol 49, 270-83 (2006). 24. Brodsky, D. Christou, H. Current concepts in intrauterine growth restriction. J Intensive Care Med 19, 307-19 (2004). 25. U.S. Department of Health and Human Services. The Health Consequences of Smoking - 50 Years of Progress: A Report of the Surgeon General. (U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014 ). 26. Doherty, S.P., Grabowski, J., Hoffman, C., Ng, S.P. Zelikoff, J.T. Early life insult from cigarette smoke may be predictive of chronic diseases later in life. Biomarkers 14, 97-101 (2009). 27. Ng, S.P. Zelikoff, J.T. Smoking during pregnancy: subsequent effects on offspring immune competence and disease vulnerability in later life. Reprod Toxicol 23, 428-37 (2007). 28. Breitling, L.P., Yang, R., Korn, B., Burwinkel, B. Brenner, H. Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet 88, 450-7 (2011). 29. Lee, K.W. Pausova, Z. Cigarette smoking and DNA methylation. Front Genet 4, 132 (2013). 30. Breton, C.V. et al. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am J Respir Crit Care Med 180, 462-7 (2009). 31. Guerrero-Preston, R. et al. Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds. Epigenetics 5, 539-46 (2010). 32. Flom, J.D. et al. Prenatal smoke exposure and genomic DNA methylation in a multiethnic birth cohort. Cancer Epidemiol Biomarkers Prev 20, 2518-23 (2011). 33. Dolinoy, D.C., Huang, D. Jirtle, R.L. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci U S A 104, 13056-61 (2007). 34. Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev 16, 6-21 (2002). 35. Suzuki, M.M. Bird, A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 9, 465-76 (2008). 36. Reik, W., Dean, W. Walter, J. Epigenetic reprogramming in mammalian development. Science 293, 1089-93 (2001). 37. Sasaki, H. Matsui, Y. Epigenetic events in mammalian germ-cell development: reprogramming and beyond. Nat Rev Genet 9, 129-40 (2008). 38. Li, S., Hursting, S.D., Davis, B.J., McLachlan, J.A. Barrett, J.C. Environmental exposure, DNA methylation, and gene regulation: lessons from diethylstilbesterol-induced cancers. Ann N Y Acad Sci 983, 161-9 (2003). 39. Painter, R.C., Roseboom, T.J. Bleker, O.P. Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod Toxicol 20, 345-52 (2005). 40. Chen, R.Z., Pettersson, U., Beard, C., Jackson-Grusby, L. Jaenisch, R. DNA hypomethylation leads to elevated mutation rates. Nature 395, 89-93 (1998). 41. Fruhwald, M.C. Plass, C. Global and gene-specific methylation patterns in cancer: aspects of tumor biology and clinical potential. Mol Genet Metab 75, 1-16 (2002). 42. Wilson, A.S., Power, B.E. Molloy, P.L. DNA hypomethylation and human diseases. Biochim Biophys Acta 1775, 138-62 (2007). 43. Terry, M.B., Delgado-Cruzata, L., Vin-Raviv, N., Wu, H.C. Santella, R.M. DNA methylation in white blood cells: association with risk factors in epidemiologic studies. Epigenetics 6, 828-37 (2011). 44. Yang, A.S. et al. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 32, e38 (2004). 45. Lander, E.S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860-921 (2001). 46. Ostertag, E.M. Kazazian, H.H., Jr. Biology of mammalian L1 retrotransposons. Annu Rev Genet 35, 501-38 (2001). 47. Gu, Z., Wang, H., Nekrutenko, A. Li, W.H. Densities, length proportions, and other distributional features of repetitive sequences in the human genome estimated from 430 megabases of genomic sequence. Gene 259, 81-8 (2000). 48. Levin, H.L. Moran, J.V. Dynamic interactions between transposable elements and their hosts. Nat Rev Genet 12, 615-27 (2011). 49. Symer, D.E. et al. Human l1 retrotransposition is associated with genetic instability in vivo. Cell 110, 327-38 (2002). 50. Esteller, M. Herman, J.G. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 196, 1-7 (2002). 51. Chalitchagorn, K. et al. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23, 8841-6 (2004). 52. Florl, A.R., Lower, R., Schmitz-Drager, B.J. Schulz, W.A. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer 80, 1312-21 (1999). 53. Hsiung, D.T. et al. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 16, 108-14 (2007). 54. Kim, M. et al. DNA methylation as a biomarker for cardiovascular disease risk. PLoS One 5, e9692 (2010). 55. Michels, K.B., Harris, H.R. Barault, L. Birthweight, maternal weight trajectories and global DNA methylation of LINE-1 repetitive elements. PLoS One 6, e25254 (2011). 56. Burris, H.H. et al. Association between birth weight and DNA methylation of IGF2, glucocorticoid receptor and repetitive elements LINE-1 and Alu. Epigenomics 5, 271-81 (2013). 57. Wilhelm-Benartzi, C.S. et al. In utero exposures, infant growth, and DNA methylation of repetitive elements and developmentally related genes in human placenta. Environ Health Perspect 120, 296-302 (2012). 58. Li, E., Bestor, T.H. Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-26 (1992). 59. Okano, M., Bell, D.W., Haber, D.A. Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247-57 (1999). 60. Delaval, K. Feil, R. Epigenetic regulation of mammalian genomic imprinting. Curr Opin Genet Dev 14, 188-95 (2004). 61. Skuse, D.H. et al. Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature 387, 705-8 (1997). 62. Nicholls, R.D. The impact of genomic imprinting for neurobehavioral and developmental disorders. J Clin Invest 105, 413-8 (2000). 63. Constancia, M., Kelsey, G. Reik, W. Resourceful imprinting. Nature 432, 53-7 (2004). 64. Reik, W. Walter, J. Genomic imprinting: parental influence on the genome. Nat Rev Genet 2, 21-32 (2001). 65. St-Pierre, J. et al. IGF2 DNA methylation is a modulator of newborn's fetal growth and development. Epigenetics 7, 1125-32 (2012). 66. Perkins, E. et al. Insulin-like growth factor 2/H19 methylation at birth and risk of overweight and obesity in children. J Pediatr 161, 31-9 (2012). 67. Hsieh, C.J. et al. The Taiwan Birth Panel Study: a prospective cohort study for environmentally-related child health. BMC research notes 4, 291 (2011). 68. Hsieh, W.S. et al. Nationwide singleton birth weight percentiles by gestational age in Taiwan, 1998-2002. Acta Paediatr Taiwan 47, 25-33 (2006). 69. Bollati, V. et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res 67, 876-80 (2007). 70. Heijmans, B.T., Kremer, D., Tobi, E.W., Boomsma, D.I. Slagboom, P.E. Heritable rather than age-related environmental and stochastic factors dominate variation in DNA methylation of the human IGF2/H19 locus. Hum Mol Genet 16, 547-54 (2007). 71. Kile, M.L. et al. Prenatal arsenic exposure and DNA methylation in maternal and umbilical cord blood leukocytes. Environ Health Perspect 120, 1061-6 (2012). 72. Huen, K. et al. Effects of age, sex, and persistent organic pollutants on DNA methylation in children. Environ Mol Mutagen 55, 209-22 (2014). 73. Watkins, D.J. et al. Associations between serum perfluoroalkyl acids and LINE-1 DNA methylation. Environ Int 63, 71-6 (2014). 74. Belancio, V.P., Deininger, P.L. Roy-Engel, A.M. LINE dancing in the human genome: transposable elements and disease. Genome Med 1, 97 (2009). 75. Nelson, H.H., Marsit, C.J. Kelsey, K.T. Global methylation in exposure biology and translational medical science. Environ Health Perspect 119, 1528-33 (2011). 76. Bjork, J.A. Wallace, K.B. Structure-activity relationships and human relevance for perfluoroalkyl acid-induced transcriptional activation of peroxisome proliferation in liver cell cultures. Toxicol Sci 111, 89-99 (2009). 77. Butenhoff, J.L. et al. Distribution of perfluorooctanesulfonate and perfluorooctanoate into human plasma lipoprotein fractions. Toxicol Lett 210, 360-5 (2012). 78. Lau, C., Butenhoff, J.L. Rogers, J.M. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198, 231-41 (2004). 79. Lau, C. et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol Sci 74, 382-92 (2003). 80. Lau, C. et al. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci 90, 510-8 (2006). 81. Luebker, D.J. et al. Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology 215, 126-48 (2005). 82. Abbott, B.D. et al. Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha. Toxicol Sci 98, 571-81 (2007). 83. Abbott, B.D. et al. Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse. Reprod Toxicol 27, 258-65 (2009). 84. Wolf, C.J., Zehr, R.D., Schmid, J.E., Lau, C. Abbott, B.D. Developmental effects of perfluorononanoic Acid in the mouse are dependent on peroxisome proliferator-activated receptor-alpha. PPAR Res 2010(2010). 85. Rusiecki, J.A. et al. Global DNA hypomethylation is associated with high serum-persistent organic pollutants in Greenlandic Inuit. Environ Health Perspect 116, 1547-52 (2008). 86. Pilsner, J.R. et al. Influence of prenatal lead exposure on genomic methylation of cord blood DNA. Environ Health Perspect 117, 1466-71 (2009). 87. Kudo, N., Suzuki-Nakajima, E., Mitsumoto, A. Kawashima, Y. Responses of the liver to perfluorinated fatty acids with different carbon chain length in male and female mice:in relation to induction of hepatomegaly, peroxisomal beta-oxidation and microsomal 1-acylglycerophosphocholine acyltransferase. Biol Pharm Bull 29, 1952-7 (2006). 88. Terry, M.B. et al. Genomic DNA methylation among women in a multiethnic New York City birth cohort. Cancer Epidemiol Biomarkers Prev 17, 2306-10 (2008). 89. Haggarty, P., Hoad, G., Horgan, G.W. Campbell, D.M. DNA methyltransferase candidate polymorphisms, imprinting methylation, and birth outcome. PLoS One 8, e68896 (2013). 90. Hoyo, C. et al. Association of cord blood methylation fractions at imprinted insulin-like growth factor 2 (IGF2), plasma IGF2, and birth weight. Cancer Causes Control 23, 635-45 (2012). 91. Feinberg, A.P., Ohlsson, R. Henikoff, S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 7, 21-33 (2006). 92. Robertson, K.D. DNA methylation and human disease. Nat Rev Genet 6, 597-610 (2005). 93. Brunaud, L. et al. Effects of vitamin B12 and folate deficiencies on DNA methylation and carcinogenesis in rat liver. Clin Chem Lab Med 41, 1012-9 (2003). | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/54854 | - |
dc.description.abstract | 背景及目的: 去氧核醣核酸甲基化(DNA methylation)是表觀遺傳修飾(epigenetic modification)的其中一種調控方式,使得基因的表現可能受到環境變化而影響。產前暴露於全氟化合物(perfluorinated compounds)和抽菸有害物質都與不良出生結果及其他健康影響有所關聯,但潛在的機制仍所知甚少。越來越多的證據顯示,發生於胚胎發育早期的表觀基因重組現象(epigenetic reprogramming)使得胎兒在子宮內發育時期相對於其他時期更易受到環境暴露影響,且此影響可能增加日後罹患某些疾病的風險。此研究目的為探討DNA甲基化(LINE-1、Alu和IGF2)的改變是否可能為產前暴露全氟化合物與抽菸有害物質和出生結果相關的潛在調控因子之一。 方法: 本研究對象為486對在2004年4月至2005年1月期間參與台灣出生世代長期追蹤研究的母嬰配對。使用超高效液相層析串聯質譜法測得臍帶血中4種全氟碳化合物,包括全氟辛烷磺酸(perfluorooctyl sulfonate, PFOS)、全氟辛酸(perfluorooctanoic acid, PFOA)、全氟壬酸(perfluorononanoic acid, PFNA)及全氟癸酸(perfluoroundecanoic acid, PFUA)。量測古丁尼(cotinine)濃度作為抽菸有害物質暴露之生物標記。使用焦磷酸測序(pyrosequencing)方法量測臍帶血中DNA重複性片段以代表全基因體甲基化程度,包括長散置式重複性片段(LINE-1)及短散置式重複性片段(Alu)。其中一個與胎兒生長發育相關的基因,類胰島素生長因子Ⅱ(insulin-like growth factor 2)被進行測定。 結果: LINE-1、Alu和IGF2 平均(標準差)甲基化程度分別為80.4(4.0)、20.8(1.7)和47.1(7.2)%(範圍:60.3-81.9、16.0-29.3和14.2-72.3)。簡單與多變項線性回歸分析顯示LINE-1甲基化程度與臍帶血中全氟辛烷磺酸濃度有顯著負相關 (簡單線性回歸: β = -1.28, p<0.01; 多變項線性回歸: β = -1.11, p<0.05)。臍帶血中較高古丁尼濃度的嬰兒與較低的LINE-1及Alu甲基化有顯著相關 (LINE-1: β = -0.81, p<0.001; Alu: β = -0.17, p<0.05) 。在高濃度古丁尼組別中,較低的LINE-1甲基化程度與較高的全氟辛烷磺酸和全氟癸酸濃度有關 (PFOS: r = -0.2, p<0.05; PFUA: r = -0.25, p<0.01)。且較低的Alu甲基化程度也與較高的全氟辛烷磺酸濃度有關 (r = -0.2, p<0.05) 。研究結果沒有發現IGF2甲基化與產前4種全氟碳化合物與抽菸有害物暴露之相關性。在甲基化與出生結果的相關性部分,早產兒比非早產兒有顯著較低的Alu甲基化程度。 結論: 我們的研究指出產前致癌物質像是全氟辛烷磺酸和抽菸有害物的暴露可能對胎兒全基因體甲基化有負面影響。此外,我們的研究也發現早產兒有較低的Alu全基因體甲基化程度。綜合以上兩點,DNA甲基化的改變可能是部分調節產前全氟辛烷磺酸與抽菸有害物質暴露和不良出生結果相關的因子之一。 | zh_TW |
dc.description.abstract | Background: DNA methylation, an essential epigenetic modification, allows gene expression to be modified in response to environmental changes. Prenatal exposures to perfluorinated compounds (PFCs) and smoking are linked to adverse birth outcomes and other health effects, but the potential mechanisms remain largely unknown. Increasing evidence suggests that during the critical period of prenatal development, fetus may be more vulnerable to environmental factors by affecting the epigenetic reprogramming and consequently increase the risk of disease development in later life. The objective of the study was to investigate whether the changes of DNA methylation (LINE-1, Alu and IGF2) may be one of the potential modulator behind the relationship between prenatal exposure (PFOS, PFOA, PFNA, PFUA and tobacco smoke) and birth outcomes. Methods: The study subjects were from the Taiwan Birth Panel Study, which were recruited from April 2004 to January 2005. Four PFCs in cord blood, including perfluorooctyl sulfonate (PFOS), perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), and perfluoroundecanoic acid (PFUA), were analyzed by ultra-high-performance liquid chromatography/tandem mass spectrometry. Cotinine were measured as a biomarker of smoking exposure. The global DNA methylation patterns were quantified in cord blood using DNA repetitive elements including long interspersed nucleotide element (LINE-1) and short interspersed nucleotide elements (Alu) by pyrosequencing. One specific gene (insulin-like growth factor 2) related to fetal growth was measured. Results: Mean (SD) methylation levels of LINE-1, Alu and IGF2 were 80.4 (4.0), 20.8 (1.7) and 47.1 (7.2) % (range: 60.3-81.9, 16.0-29.3 and 14.2-72.3), respectively. Simple and multiple linear regression models shown a significant association between LINE-1 methylation level and cord blood PFOS concentration (crude model: β = -1.28, p<0.01; adjusted model: β= -1.11, p<0.05). Lower LINE-1 and Alu methylation level was associated with higher PFOS and PFUA concentrations in high cotinine group (LINE-1, PFOS: r = -0.2, p<0.05; PFUA: r = -0.25, p<0.01; Alu, PFOS: r = -0.2, p<0.05). The infants with higher cotinine level had a significantly lower LINE-1 and Alu methylation levels (LINE-1: β = -0.81, p<0.001; Alu: β = -0.17, p<0.05). No significant associations were found between prenatal 4 major PFCs and cotinine exposure and IGF2 gene methylation level. Infants had significant difference on Alu methylation level between preterm birth and not preterm birth, with preterm birth having a lower average methylation level of Alu than not preterm birth. Conclusions: Our results suggest that prenatal exposure to potentially carcinogenic compounds such as PFOS and tobacco smoke may have adverse impact on fetal global DNA methylation patterns. Otherwise, our finding shown that lower global DNA methylation level of Alu was associated with preterm birth. Together, DNA methylation changes may be one of the possible modulator of the relationships between prenatal PFOS and tobacco exposure and adverse birth outcome. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T03:39:57Z (GMT). No. of bitstreams: 1 ntu-103-R01844006-1.pdf: 2080974 bytes, checksum: f454835b788d9f0573cdfed136157659 (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | 口試委員會審定書 i 誌謝 ii 中文摘要 iii ABSTRACT v CONTENTS vii LIST OF TABLES ix Chapter 1 Introduction 1 1.1 Prenatal exposure 1 1.1.1 Perfluorinated compounds (PFCs) 1 1.1.2 Tobacco smoke 2 1.2 DNA methylation 3 1.3 Prenatal exposure, global DNA hypomethylation and birth outcomes 4 1.4 Fetal growth related gene: Insulin-like Growth Factor 2 (IGF2) 7 1.5 Study objective 8 Chapter 2 Materials and Methods 9 2.1 Study subjects 9 2.2 Exposure information 10 2.3 Birth outcomes 11 2.4 Laboratory methods 12 2.4.1 Bisulfite treatment 12 2.4.2 PCR with primers specific for bisulfite-converted DNA 12 2.4.3 Pyrosequencing 13 2.5 Statistical analysis 15 Chapter 3 Results 16 Chapter 4 Discussion 20 4.1 Prenatal exposure and DNA methylation 20 4.2 Birth outcomes and DNA methylation 26 4.3 Strength and limitations 29 Chapter 5 Conclusions 31 REFERENCE 32 TABLES 37 APPENDIX 47 | |
dc.language.iso | en | |
dc.title | 產前全氟碳化物及抽菸暴露和早產兒對新生兒臍帶血去氧核醣核酸甲基化之影響 | zh_TW |
dc.title | Influence of Preterm Birth and Prenatal Exposure to Perfluorinated Compounds and Tobacco Smoke on Methylation of Cord Blood DNA | en |
dc.type | Thesis | |
dc.date.schoolyear | 103-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 陳保中(Pau-Chung Chen),邱弘毅(Hung-Yi Chiou) | |
dc.subject.keyword | 表基因,去氧核醣核酸甲基化,產前暴露,全氟碳化物,抽菸有害物,出生結果, | zh_TW |
dc.subject.keyword | epigenetic,DNA methylation,prenatal exposure,perfluorinated compounds,tobacco smoke,birth outcomes, | en |
dc.relation.page | 61 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2015-02-16 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 環境衛生研究所 | zh_TW |
顯示於系所單位: | 環境衛生研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf 目前未授權公開取用 | 2.03 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。